Sectoral Asset Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,160
Closed -$3.86M 121
2020
Q4
$3.86M Hold
4,160
0.27% 72
2020
Q3
$4.28M Buy
4,160
+3,652
+719% +$3.93M 0.37% 68
2020
Q2
$515K Sell
508
-12,912
-96% -$12M 0.05% 140
2020
Q1
$11.7M Sell
13,420
-1,252
-9% -$1.24M 2.24% 12
2019
Q4
$15.7M Buy
14,672
+1,334
+10% +$1.36M 2.35% 12
2019
Q3
$12.3M Buy
13,338
+1,232
+10% +$1.35M 2.13% 16
2019
Q2
$13.7M Buy
12,106
+8,856
+272% +$9.69M 1.64% 21
2019
Q1
$4.42M Buy
+3,250
New +$4.41M 0.53% 59

Other funds holding KYNB

Sectoral Asset Management's KYNB Position: Q1 2021 in Review

Sectoral Asset Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 4,160 shares — an estimated $3.86M sold.

Sectoral Asset Management first reported a position in KYNB in Q1 2019 and held it in 8 quarters. The position peaked at $15.7M in Q4 2019. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Sectoral Asset Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Sectoral Asset Management sold 4,160 Kyntra Bio shares in Q1 2021, an estimated $3.86M.
  • Sectoral Asset Management first reported a position in Kyntra Bio in Q1 2019 and held it in 8 quarters.
  • Sectoral Asset Management's Kyntra Bio position peaked at $15.7M in Q4 2019.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Sectoral Asset Management's 13F filing for Q1 2021, filed 14 May 2021.